Financhill
Buy
58

MORN Quote, Financials, Valuation and Earnings

Last price:
$308.76
Seasonality move :
5.86%
Day range:
$304.34 - $309.35
52-week range:
$250.34 - $365.00
Dividend yield:
0.56%
P/E ratio:
34.65x
P/S ratio:
5.75x
P/B ratio:
8.10x
Volume:
170.5K
Avg. volume:
198.5K
1-year change:
7.3%
Market cap:
$13B
Revenue:
$2.3B
EPS (TTM):
$8.90

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MORN
Morningstar
$585.8M $2.06 5.94% 38.29% $338.33
CME
CME Group
$1.7B $2.81 9.35% 22.71% $271.12
MCO
Moodys
$1.9B $3.54 0.15% 8.83% $501.35
MSCI
MSCI
$744.5M $3.90 7.64% 21.53% $614.53
NDAQ
Nasdaq
$1.2B $0.77 -29.86% 107.64% $84.00
VALU
Value Line
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MORN
Morningstar
$308.42 $338.33 $13B 34.65x $0.46 0.56% 5.75x
CME
CME Group
$289.00 $271.12 $104.1B 29.07x $1.25 3.63% 16.56x
MCO
Moodys
$479.32 $501.35 $86.2B 41.39x $0.94 0.75% 12.07x
MSCI
MSCI
$564.02 $614.53 $43.6B 38.76x $1.80 1.21% 15.16x
NDAQ
Nasdaq
$83.54 $84.00 $48B 37.97x $0.24 1.15% 6.20x
VALU
Value Line
$39.19 -- $368.9M 17.19x $0.33 3.13% 10.34x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MORN
Morningstar
33.31% 0.919 6.31% 1.00x
CME
CME Group
11.23% -0.278 3.58% 0.02x
MCO
Moodys
64.84% 1.605 8.14% 1.39x
MSCI
MSCI
126.71% 0.930 10.36% 0.75x
NDAQ
Nasdaq
44.68% 1.313 21.42% 0.44x
VALU
Value Line
-- 0.394 0.76% 3.39x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MORN
Morningstar
$350.5M $114.1M 16.24% 25.24% 20.18% $58.8M
CME
CME Group
$1.4B $1.1B 11.8% 13.28% 78.34% $1.1B
MCO
Moodys
$1.4B $881M 19.14% 54.49% 46.21% $672M
MSCI
MSCI
$609M $377M 30.82% -- 50.62% $268.9M
NDAQ
Nasdaq
$816M $576M 6.14% 11.5% 27.75% $614M
VALU
Value Line
$5.3M $1.6M 22.91% 22.91% 17.44% $6.7M

Morningstar vs. Competitors

  • Which has Higher Returns MORN or CME?

    CME Group has a net margin of 13.49% compared to Morningstar's net margin of 58.22%. Morningstar's return on equity of 25.24% beat CME Group's return on equity of 13.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.23% $1.82 $2.4B
    CME
    CME Group
    87.41% $2.62 $30.5B
  • What do Analysts Say About MORN or CME?

    Morningstar has a consensus price target of $338.33, signalling upside risk potential of 9.7%. On the other hand CME Group has an analysts' consensus of $271.12 which suggests that it could fall by -6.19%. Given that Morningstar has higher upside potential than CME Group, analysts believe Morningstar is more attractive than CME Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    1 1 0
    CME
    CME Group
    4 7 0
  • Is MORN or CME More Risky?

    Morningstar has a beta of 0.994, which suggesting that the stock is 0.607% less volatile than S&P 500. In comparison CME Group has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.307%.

  • Which is a Better Dividend Stock MORN or CME?

    Morningstar has a quarterly dividend of $0.46 per share corresponding to a yield of 0.56%. CME Group offers a yield of 3.63% to investors and pays a quarterly dividend of $1.25 per share. Morningstar pays 18.74% of its earnings as a dividend. CME Group pays out 101.66% of its earnings as a dividend. Morningstar's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

  • Which has Better Financial Ratios MORN or CME?

    Morningstar quarterly revenues are $581.9M, which are smaller than CME Group quarterly revenues of $1.6B. Morningstar's net income of $78.5M is lower than CME Group's net income of $956.2M. Notably, Morningstar's price-to-earnings ratio is 34.65x while CME Group's PE ratio is 29.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 5.75x versus 16.56x for CME Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
    CME
    CME Group
    16.56x 29.07x $1.6B $956.2M
  • Which has Higher Returns MORN or MCO?

    Moodys has a net margin of 13.49% compared to Morningstar's net margin of 32.48%. Morningstar's return on equity of 25.24% beat Moodys's return on equity of 54.49%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.23% $1.82 $2.4B
    MCO
    Moodys
    74.48% $3.46 $10.7B
  • What do Analysts Say About MORN or MCO?

    Morningstar has a consensus price target of $338.33, signalling upside risk potential of 9.7%. On the other hand Moodys has an analysts' consensus of $501.35 which suggests that it could grow by 4.6%. Given that Morningstar has higher upside potential than Moodys, analysts believe Morningstar is more attractive than Moodys.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    1 1 0
    MCO
    Moodys
    10 11 0
  • Is MORN or MCO More Risky?

    Morningstar has a beta of 0.994, which suggesting that the stock is 0.607% less volatile than S&P 500. In comparison Moodys has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.353%.

  • Which is a Better Dividend Stock MORN or MCO?

    Morningstar has a quarterly dividend of $0.46 per share corresponding to a yield of 0.56%. Moodys offers a yield of 0.75% to investors and pays a quarterly dividend of $0.94 per share. Morningstar pays 18.74% of its earnings as a dividend. Moodys pays out 30.13% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or MCO?

    Morningstar quarterly revenues are $581.9M, which are smaller than Moodys quarterly revenues of $1.9B. Morningstar's net income of $78.5M is lower than Moodys's net income of $625M. Notably, Morningstar's price-to-earnings ratio is 34.65x while Moodys's PE ratio is 41.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 5.75x versus 12.07x for Moodys. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
    MCO
    Moodys
    12.07x 41.39x $1.9B $625M
  • Which has Higher Returns MORN or MSCI?

    MSCI has a net margin of 13.49% compared to Morningstar's net margin of 38.7%. Morningstar's return on equity of 25.24% beat MSCI's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.23% $1.82 $2.4B
    MSCI
    MSCI
    81.66% $3.71 $3.6B
  • What do Analysts Say About MORN or MSCI?

    Morningstar has a consensus price target of $338.33, signalling upside risk potential of 9.7%. On the other hand MSCI has an analysts' consensus of $614.53 which suggests that it could grow by 8.96%. Given that Morningstar has higher upside potential than MSCI, analysts believe Morningstar is more attractive than MSCI.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    1 1 0
    MSCI
    MSCI
    7 6 0
  • Is MORN or MSCI More Risky?

    Morningstar has a beta of 0.994, which suggesting that the stock is 0.607% less volatile than S&P 500. In comparison MSCI has a beta of 1.330, suggesting its more volatile than the S&P 500 by 33.042%.

  • Which is a Better Dividend Stock MORN or MSCI?

    Morningstar has a quarterly dividend of $0.46 per share corresponding to a yield of 0.56%. MSCI offers a yield of 1.21% to investors and pays a quarterly dividend of $1.80 per share. Morningstar pays 18.74% of its earnings as a dividend. MSCI pays out 45.9% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or MSCI?

    Morningstar quarterly revenues are $581.9M, which are smaller than MSCI quarterly revenues of $745.8M. Morningstar's net income of $78.5M is lower than MSCI's net income of $288.6M. Notably, Morningstar's price-to-earnings ratio is 34.65x while MSCI's PE ratio is 38.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 5.75x versus 15.16x for MSCI. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
    MSCI
    MSCI
    15.16x 38.76x $745.8M $288.6M
  • Which has Higher Returns MORN or NDAQ?

    Nasdaq has a net margin of 13.49% compared to Morningstar's net margin of 18.9%. Morningstar's return on equity of 25.24% beat Nasdaq's return on equity of 11.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.23% $1.82 $2.4B
    NDAQ
    Nasdaq
    39.04% $0.68 $20.9B
  • What do Analysts Say About MORN or NDAQ?

    Morningstar has a consensus price target of $338.33, signalling upside risk potential of 9.7%. On the other hand Nasdaq has an analysts' consensus of $84.00 which suggests that it could grow by 0.55%. Given that Morningstar has higher upside potential than Nasdaq, analysts believe Morningstar is more attractive than Nasdaq.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    1 1 0
    NDAQ
    Nasdaq
    6 5 0
  • Is MORN or NDAQ More Risky?

    Morningstar has a beta of 0.994, which suggesting that the stock is 0.607% less volatile than S&P 500. In comparison Nasdaq has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.022%.

  • Which is a Better Dividend Stock MORN or NDAQ?

    Morningstar has a quarterly dividend of $0.46 per share corresponding to a yield of 0.56%. Nasdaq offers a yield of 1.15% to investors and pays a quarterly dividend of $0.24 per share. Morningstar pays 18.74% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or NDAQ?

    Morningstar quarterly revenues are $581.9M, which are smaller than Nasdaq quarterly revenues of $2.1B. Morningstar's net income of $78.5M is lower than Nasdaq's net income of $395M. Notably, Morningstar's price-to-earnings ratio is 34.65x while Nasdaq's PE ratio is 37.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 5.75x versus 6.20x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
    NDAQ
    Nasdaq
    6.20x 37.97x $2.1B $395M
  • Which has Higher Returns MORN or VALU?

    Value Line has a net margin of 13.49% compared to Morningstar's net margin of 57.58%. Morningstar's return on equity of 25.24% beat Value Line's return on equity of 22.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.23% $1.82 $2.4B
    VALU
    Value Line
    59.6% $0.55 $99M
  • What do Analysts Say About MORN or VALU?

    Morningstar has a consensus price target of $338.33, signalling upside risk potential of 9.7%. On the other hand Value Line has an analysts' consensus of -- which suggests that it could fall by --. Given that Morningstar has higher upside potential than Value Line, analysts believe Morningstar is more attractive than Value Line.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    1 1 0
    VALU
    Value Line
    0 0 0
  • Is MORN or VALU More Risky?

    Morningstar has a beta of 0.994, which suggesting that the stock is 0.607% less volatile than S&P 500. In comparison Value Line has a beta of 1.081, suggesting its more volatile than the S&P 500 by 8.115%.

  • Which is a Better Dividend Stock MORN or VALU?

    Morningstar has a quarterly dividend of $0.46 per share corresponding to a yield of 0.56%. Value Line offers a yield of 3.13% to investors and pays a quarterly dividend of $0.33 per share. Morningstar pays 18.74% of its earnings as a dividend. Value Line pays out 55.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or VALU?

    Morningstar quarterly revenues are $581.9M, which are larger than Value Line quarterly revenues of $9M. Morningstar's net income of $78.5M is higher than Value Line's net income of $5.2M. Notably, Morningstar's price-to-earnings ratio is 34.65x while Value Line's PE ratio is 17.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 5.75x versus 10.34x for Value Line. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    5.75x 34.65x $581.9M $78.5M
    VALU
    Value Line
    10.34x 17.19x $9M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock